Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cadence Biomedical is a private medical device company focused on neurorehabilitation and mobility assistance for people with gait impairment caused by stroke, spinal cord injury, multiple sclerosis, and related neurological conditions. Its primary commercial product is Kickstart, a wearable walking assistance and physical therapy device that uses the company’s proprietary Exotendon technology to provide stability, guided leg movement, and step assistance without batteries or electrical stimulation. The company markets Kickstart for use both in rehabilitation settings and as a prescribed device for home and community use. Cadence Biomedical originated from technology licensed from the Cleveland Clinic and has positioned itself as a developer of kinetic orthotic systems for severe mobility impairment. The company appears to remain active as a private Seattle-based healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cadence Biomedical.